Holdings in Company

Paris, France and Camberley, UK – 6 January 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex SA (“Biosynex”) on 5 January 2023 that, as at 3 January 2023, Biosynex’s holding in the Company on a voting and capital basis is 2.88% (2,030,916 shares).